BiPar Sciences Acquired By Sanofi-aventis
French biotech firm Sanofi-aventis said Wednesday that the firm has signed an agreement to acquire Brisbane, California-based BiPar Sciences. BiPar is a developer of cancer treatments. According to the firms, the deal is worth up to $500M, depending on milestone payments. Bipar is venture funded by Asset Management Company, Canaan Partners, Domain Associates, Lighthouse Capital Partners, Polytechnos, Quantum Technology Partners, and Vulcan Capital.
posted on Wednesday, April 15, 2009
Related companies:
BiPar Sciences
Related stories:
> BiPar Sciences Finds $35M
> BiPar Sciences Raises $20M In Debt, Equity
> Aesthetics Sciences Raises $6M
> PayPal Buys Fraud Sciences Ltd. For $169M
> GenoLogics Acquired By Illumina
silicontap.com Home